Publications by authors named "S Gooding"

Claim this Profile
N
NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma.
Gaurav Agarwal, Mohammad Kazeroun, Mirian Salazar, Khrystal McBean, Ananya Kannan, Sarah Gooding

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study.
Dipal Mehta, Robert Cicero, Laura Chiecchio, Samir Asher, Martin Kaiser, Sarah Gooding

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond.
Phaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, Sarah Gooding, Wee Joo Chng

Haematologica· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative liver function imaging and whole genome sequencing - Effective modalities for a new era in personalised decision-making for operable colorectal liver metastases?
Fenella Welsh, Senthil Sundaravadanan, Pulkit Sethi, Mohammad Kazeroun, Alessandro Fichera, Sarah Gooding

HPB (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAR1 in lenalidomide resistance: still immunomodulation?
Sarah Gooding

Blood· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis